ATC kodu L01

L01A Alkilleyici ajanlar

L01AA Azotlu hardal analogları
L01AA01 Siklofosfamid
L01AA02 Klorambusil
L01AA03 Melfalan
L01AA05 Klormethin
L01AA06 İfosfamid
L01AA07 Trofosfamid
L01AA08 Prednimustin
L01AA09 Bendamustin
L01AA10 Melphalan flufenamid

L01AB Alkil sülfonatlar
L01AB01 Busulfan
L01AB02 Treosulfan
L01AB03 Mannosulfan

L01AC Etilen iminler
L01AC01 Thiotepa
L01AC02 Triazikuon
L01AC03 Karbokuon

L01AD Nitrozüreler
L01AD01 Karmustin
L01AD02 Lomustin
L01AD03 Semustin
L01AD04 Streptozosin
L01AD05 Fotemustin
L01AD06 Nimustin
L01AD07 Ranimustin
L01AD08 Uramustin

L01AG Epoksidler
L01AG01 Etoglucid

L01AX Diğer alkilleyici ajanlar
L01AX01 Mitobronitol
L01AX02 Pipobroman
L01AX03 Temozolomid
L01AX04 Dakarbazin

L01B Antimetabolitler

L01BA Folik asit analogları
L01BA01 Metotreksat
L01BA03 Raltitreksed
L01BA04 Pemetreksed
L01BA05 Pralatreksat

L01BB Pürin analogları
L01BB02 Mercaptopurin
L01BB03 Tioguanin
L01BB04 Cladribin
L01BB05 Fludarabin
L01BB06 Clofarabin
L01BB07 Nelarabin
QL01BB90 Rabacfosadin

L01BC Pirimidin analogları
L01BC01 Cytarabin
L01BC02 Fluorouracil
L01BC03 Tegafur
L01BC04 Carmofur
L01BC05 Gemcitabin
L01BC06 Capecitabin
L01BC07 Azacitidin
L01BC08 Decitabin
L01BC09 Floksuridin
L01BC52 Fluorouracil, kombinasyonlar
L01BC53 Tegafur, kombinasyonlar
L01BC58 Decitabine, kombinasyonlar
L01BC59 Trifluridin, kombinasyonlar

L01C Bitki alkaloidleri ve diğer doğal ürünler

L01CA Cezayir menekşesi alkaloidleri ve analogları
L01CA01 Vinblastin
L01CA02 Vinkristin
L01CA03 Vindesin
L01CA04 Vinorelbin
L01CA05 Vinflunin
L01CA06 Vintafolid

L01CB Podofillotoksin türevleri
L01CB01 Etoposid
L01CB02 Teniposid

L01CC Kolşisin türevleri
L01CC01 Demekolsin

L01CD Taksanlar
L01CD01 Paklitaksel
L01CD02 Doketaksel
L01CD03 Paklitaksel poliglumeks
L01CD04 Kabazitaksel
L01CD51 Paklitaksel ve enkekuidar

L01CE Topoizomeraz 1 (TOP1) inhibitörleri
L01CE01 Topotecan
L01CE02 İrinotecan
L01CE03 Etirinotecan pegol
L01CE04 Belotecan

L01CX Diğer bitki alkaloidleri ve doğal ürünler
L01CX01 Trabektedin

L01D Sitotoksik antibiyotikler ve ilişkili maddeler

L01DA Aktinomisinler
L01DA01 Daktinomisin

L01DB Antrasikinler ve ilişkili maddeler
L01DB01 Doksorubisin
L01DB02 Daunorubisin
L01DB03 Epirubisin
L01DB04 Aklarubisin
L01DB05 Zorubisin
L01DB06 İdarubisin
L01DB07 Mitoksantron
L01DB08 Pirarubisin
L01DB09 Valrubisin
L01DB10 Amrubisin
L01DB11 Piksantron

L01DC Diğer sitotoksik antibiyotikler
L01DC01 Bleomisin
L01DC02 Plikamisin
L01DC03 Mitomisin
L01DC04 İksabepilon
L01DC05 Utidelon

L01E Protein kinaz inhibitörleri

L01EA BCR-ABL tirosin kinaz inhibitörleri
L01EA01 İmatinib
L01EA02 Dasatinib
L01EA03 Nilotinib
L01EA04 Bosutinib
L01EA05 Ponatinib
L01EA06 Asciminib

L01EB Epidermal büyüme faktörü reseptörü (EGFR) tirosin kinaz inhibitörleri
L01EB01 Gefitinib
L01EB02 Erlotinib
L01EB03 Afatinib
L01EB04 Osimertinib
L01EB05 Rociletinib
L01EB06 Olmutinib
L01EB07 Dacomitinib
L01EB08 İcotinib
L01EB09 Lazertinib
L01EB10 Mobocertinib
L01EB11 Aumolertinib
L01EB12 Firmonertinib

L01EC B-Raf serin-treonin kinaz (BRAF) inhibitörleri
L01EC01 Vemurafenib
L01EC02 Dabrafenib
L01EC03 Encorafenib
L01EC04 Tovorafenib

L01ED Anaplastik lösemik kinaz (ALK) inhibitörleri
L01ED01 Crizotinib
L01ED02 Ceritinib
L01ED03 Alectinib
L01ED04 Brigatinib
L01ED05 Lorlatinib

L01EE Mitojen aktive protein kinaz (MEK) inhibitörleri
L01EE01 Trametinib
L01EE02 Cobimetinib
L01EE03 Binimetinib
L01EE04 Selumetinib
L01EE05 Mirdametinib
L01EE06 Tunlametinib

L01EF Siklin bağımlı kinaz (CDK) inhibitörleri
L01EF01 Palbosiklib
L01EF02 Ribosiklib
L01EF03 Abemasiklib

L01EG Rapamisin hedefi olan (mTOR) kinaz inhibitörleri
L01EG01 Temsirolimus
L01EG02 Everolimus
L01EG03 Ridaforolimus
L01EG04 Sirolimus

L01EH İnsan epidermal büyüme faktörü reseptör 2 (HER2) tirozin kinaz inhibitörleri
L01EH01 Lapatinib
L01EH02 Neratinib
L01EH03 Tukatinib
L01EH04 Zongertinib
L01EH05 Mifanertinib
L01EH06 Sevabertinib

L01EJ Janus ile ilişkili kinaz (JAK) inhibitörleri
L01EJ01 Ruksolitinib
L01EJ02 Fedratinib
L01EJ03 Pacritinib
L01EJ04 Momelotinib

L01EK Damar endoteli büyüme faktörü reseptörü (VEGFR) tirozin kinaz inhibitörleri
L01EK01 Aksitinib
L01EK02 Cediranib
L01EK03 Tivozanib
L01EK04 Frukuintinib
L01EK05 Rivoceranib

L01EL Bruton tirozin kinaz (BTK) inhibitörleri
L01EL01 İbrutinib
L01EL02 Acalabrutinib
L01EL03 Zanubrutinib
L01EL04 Orelabrutinib
L01EL05 Pirtobrutinib
L01EL06 Tirabrutinib

L01EM Fosfatidilinozitol-3-kinaz (Pi3K) inhibitörleri
L01EM01 İdelalisib
L01EM02 Copanlisib
L01EM03 Alpelisib
L01EM04 Duvelisib
L01EM05 Parsaclisib
L01EM06 İnavolisib

L01EN Fibroblast büyüme faktörü reseptörü (FGFR) tirozin kinaz inhibitörleri
L01EN01 Erdafitinib
L01EN02 Pemigatinib
L01EN03 İnfigratinib
L01EN04 Futibatinib

L01EP	Hüsresel mezenkimal epitelyal geçiş fakötrü (c-MET) kinaz inhibitörleri
L01EP01 Kapmatinib
L01EP02 Tepotinib
L01EP03 Savolitinib

L01EX Diğer protein kinaz inhibitörleri
L01EX01 Sunitinib
L01EX02 Sorafenib
L01EX03 Pazopanib
L01EX04 Vandetanib
L01EX05 Regorafenib
L01EX06 Masitinib
L01EX07 Kabozantinib
L01EX08 Lenvatinib
L01EX09 Nintedanib
L01EX10 Midostaurin
L01EX11 Kuizartinib
L01EX12 Larotrectinib
L01EX13 Gilteritinib
L01EX14 Entrectinib
L01EX15 Peksidartinib
L01EX18 Avapritinib
L01EX19 Ripretinib
L01EX22 Selpercatinib
L01EX23 Pralsetinib
L01EX24 Surufatinib
L01EX25 Umbralisib
L01EX26 Sitravatinib
L01EX27 Kapivasertib
L01EX28 Repotrectinib
L01EX29 Vimseltinib
QL01EX90 Toceranib

L01F Monoklonal antikorlar ve antikor ilaç bağlayıcılar 

L01FA CD20 (başkalaşım kümesi 20) inhibitörleri
L01FA01 Rituksimab
L01FA02 Ofatumumab
L01FA03 Obinutuzumab

L01FB CD22 (başkalaşım kümesi 22) inhibitörleri
L01FB01 İnotuzumab ozogamisin
L01FB02 Moksetumomab pasudotoks

L01FC CD38 (başkalaşım kümesi 38) inhibitörleri
L01FC01 Daratumumab
L01FC02 İsatuksimab

L01FD HER2 (insan epidermal büyüme faktörü reseptörü 2) inhibitörleri
L01FD01 Trastuzumab
L01FD02 Pertuzumab
L01FD03 Trastuzumab emtansin
L01FD04 Trastuzumab derukstecan
L01FD05 Trastuzumab duokarmazin
L01FD06 Margetuksimab
L01FD07 Zanidatamab

L01FE EGFR (epidermal büyüme faktörü reseptörü) inhibitörleri
L01FE01 Cetuksimab
L01FE02 Panitumumab
L01FE03 Necitumumab

L01FF PD-1/PDL-1 (programlanmış hücre ölümü proteini 1/ ölüm ligandı 1) inhibitörleri
L01FF01 Nivolumab
L01FF02 Pembrolizumab
L01FF03 Durvalumab
L01FF04 Avelumab
L01FF05 Atezolizumab
L01FF06 Cemiplimab
L01FF07 Dostarlimab
L01FF08 Prolgolimab
L01FF09 Tislelizumab
L01FF10 Retifanlimab
L01FF11 Sugemalimab
L01FF12 Serplulimab
L01FF13 Toripalimab
L01FF14 Camrelizumab
L01FF15 Envafolimab
L01FF16 Sasanlimab

L01FG VEGF/VEGFR (vasküler endotelyal büyüme faktörü) inhibitörleri
L01FG01 Bevakizumab
L01FG02 Ramukirumab

L01FX Diğer monoklonal antikorlar ve antikor ilaç konjugatları 
L01FX01 Edrekolomab
L01FX02 Gemtuzumab ozogamisin
L01FX03 Katumaksomab
L01FX04 İpilimumab
L01FX05 Brentuksimab vedotin
L01FX06 Dinutuksimab beta
L01FX07 Blinatumomab
L01FX08 Elotuzumab
L01FX09 Mogamulizumab
L01FX10 Olaratumab
L01FX11 Bermekimab
L01FX12 Tafasitamab
L01FX13 Enfortumab vedotin
L01FX14 Polatuzumab vedotin
L01FX15 Belantamab mafodotin
L01FX16 Oportuzumab monatoks
L01FX17 Sacituzumab govitecan
L01FX18 Amivantamab
L01FX19 Sabatolimab
L01FX20 Tremelimumab
L01FX21 Naksitamab
L01FX22 Loncastuksimab tesirin
L01FX23 Tisotumab vedotin
L01FX24 Teklistamab
L01FX25 Mosunetuzumab
L01FX26 Mirvetuksimab soravtansin
L01FX27 Epkoritamab
L01FX28 Glofitamab
L01FX29 Talkuetamab
L01FX31 Zolbetuksimab
L01FX32 Elranatamab
L01FX33 Tarlatamab
L01FX34 Odronekstamab
L01FX35 Datopotamab derukstecan
L01FX36 Patritumab derukstecan
L01FX37 Linvoseltamab
L01FX38 İfinatamab derukstecan
L01FX39 Bemarituzumab

L01FY Monoklonal antikorlar ve antikor ilaç konjugatlarının kombinasyonları
L01FY01 Pertuzumab ve trastuzumab
L01FY02 Nivolumab ve relatlimab
L01FY03 Prolgolimab ve nurulimab

L01X Diğer antineoplastik ajanlar

L01XA Platin bileşikleri
L01XA01 Cisplatin
L01XA02 Karboplatin
L01XA03 Oksaliplatin
L01XA04 Satraplatin
L01XA05 Polyplatillen

L01XB Metilhidrazinler
L01XB01 Procarbazin

L01XD Fotodiyot ile terapi için kullanılan duyarlaştırıcılar
L01XD01 Porfimer sodyum
L01XD03 Metil aminolevulinat
L01XD04 Aminolevulinik asit
L01XD05 Temoporfin
L01XD06 Efaproksiral
L01XD07 Padeliporfin

L01XF Kanser tedavisi için retinoidler
L01XF01 Tretinoin
L01XF02 Alitretinoin
L01XF03 Beksaroten

L01XG Proteazom inhibitörleri
L01XG01 Bortezomib
L01XG02 Carfilzomib
L01XG03 İksazomib

L01XH Histon deasetilaz (HDAC) inhibitörleri
L01XH01 Vorinostat
L01XH02 Romidepsin
L01XH03 Panobinostat
L01XH04 Belinostat
L01XH05 Entinostat
L01XH06 Tucidinostat
L01XH07 Resminostat

L01XJ Hedgehog yolağı inhibitörleri
L01XJ01 Vismodegib
L01XJ02 Sonidegib
L01XJ03 Glasdegib

L01XK Poli (ADP-riboz) polimeraz (PARP) inhibitörleri 
L01XK01 Olaparib
L01XK02 Niraparib
L01XK03 Rukaparib
L01XK04 Talazoparib
L01XK05 Veliparib
L01XK06 Pamiparib
L01XK07 Senaparib
L01XK52 Niraparib ve abirateron

L01XL Antineoplastik hücre ve gen tedavisi 
L01XL01 Sitimagene ceradenovec
L01XL02 Talimogene laherparepvec
L01XL03 Aksicabtagene ciloleucel
L01XL04 Tisagenlecleucel
L01XL05 Ciltacabtagene autoleucel
L01XL06 Breksucabtagene autoleucel
L01XL07 İdecabtagene vicleucel
L01XL08 Lisocabtagene maraleucel
L01XL09 Tabelecleucel
L01XL10 Nadofaragene firadenovec
L01XL11 Lifileucel
L01XL12 Obecabtagene autoleucel

L01XM İzositrat dehidrojenaz (IDH) inhibitörleri
L01XM01 Enasidenib
L01XM02 İvosidenib
L01XM03 Olutasidenib
L01XM04 Vorasidenib

L01XX Diğer antineoplastik ajanlar
L01XX01 Amsacrin
L01XX02 Asparaginas
L01XX03 Altretamin
L01XX05 Hidroksicarbamid
L01XX07 Lonidamin
L01XX08 Pentostatin
L01XX10 Masoprocol
L01XX11 Estramustin
L01XX16 Mitoguazon
L01XX18 Tiazofurin
L01XX23 Mitotan
L01XX24 Pegaspargas
L01XX27 Arsenic trioksid
L01XX29 Denileukin diftitoks
L01XX33 Celecoksib
L01XX35 Anagrelid
L01XX36 Oblimersen
L01XX40 Omasetaksin mepesukkinat
L01XX41 Eribulin
L01XX44 Aflibercept
L01XX46 Olaparib
L01XX52 Venetoklaks
L01XX53 Vosaroksin
L01XX57 Plitidepsin
L01XX58 Epacadostat
L01XX66 Selineksor
L01XX67 Tagraksofusp
L01XX69 Lurbinectedin
L01XX72 Tazemetostat
L01XX73 Sotorasib
L01XX74 Belzutifan
L01XX75 Tebentafusp
L01XX77 Adagrasib
L01XX78 Navitoklaks
L01XX79 Eflornitin
L01XX80 İmetelstat
L01XX81 Nirogacestat
L01XX82 Darinaparsin
L01XX83 Para-toluensülfonamid
L01XX84 Pelabresib
L01XX85 İdroksioleik asit
L01XX86 Kalaspargaz pegol
L01XX87 Revumenib
QL01XX91 Tigilanol tiglat
QL01XX92 Verdineksor

L01XY Antineoplastik ajan kombinasyonları
L01XY01 Sitarabin ve daunorubisin
L01XY04 Bifikafusp alfa ve onfekafusp alfa

 Kaynakça 

L01